{"pmid":32436998,"title":"Lack of viral transmission to preterm newborn from a COVID-19 positive breastfeeding mother at 11 days postpartum.","text":["Lack of viral transmission to preterm newborn from a COVID-19 positive breastfeeding mother at 11 days postpartum.","In December 2019, novel coronavirus 2019 has appeared in China. On 11 February 2020, the World Health Organization officially names the disease as COVID-19.(1) The new coronavirus is highly contagious. The rapid spread of SARS-CoV-2 lead to declare the pandemic on the 11(th) March 2020. On 10 May 2020 the number of infected people is 4,132,373 worldwide.(2) This article is protected by copyright. All rights reserved.","J Med Virol","Perrone, Serafina","Giordano, Maurizio","Meoli, Antonello","Deolmi, Michela","Marinelli, Francesca","Messina, Giulia","Lugani, Paola","Moretti, Sabrina","Esposito, Susanna","32436998"],"abstract":["In December 2019, novel coronavirus 2019 has appeared in China. On 11 February 2020, the World Health Organization officially names the disease as COVID-19.(1) The new coronavirus is highly contagious. The rapid spread of SARS-CoV-2 lead to declare the pandemic on the 11(th) March 2020. On 10 May 2020 the number of infected people is 4,132,373 worldwide.(2) This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Perrone, Serafina","Giordano, Maurizio","Meoli, Antonello","Deolmi, Michela","Marinelli, Francesca","Messina, Giulia","Lugani, Paola","Moretti, Sabrina","Esposito, Susanna"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32436998","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1002/jmv.26037","keywords":["coronavirus","epidemiology","horizontal transmission","sars coronavirus","virus classification"],"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1667521393532600321,"score":9.490897,"similar":[{"pmid":32449972,"title":"Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID-19 and Mycoplasma pneumoniae in the USA.","text":["Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID-19 and Mycoplasma pneumoniae in the USA.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is spreading at a rapid pace, and the World Health Organization declared it as pandemic on 11 March 2020. Mycoplasma pneumoniae is an \"atypical\" bacterial pathogen commonly known to cause respiratory illness in humans. The coinfection from SARS-CoV-2 and mycoplasma pneumonia is rarely reported in the literature to the best of our knowledge. We present a study in which 6 of 350 patients confirmed with COVID-19 were also diagnosed with M. pneumoniae infection. In this study, we described the clinical characteristics of patients with coinfection. Common symptoms at the onset of illness included fever (six [100%] patients); five (83.3%) patients had a cough, shortness of breath, and fatigue. The other symptoms were myalgia (66.6%), gastrointestinal symptoms (33.3%-50%), and altered mental status (16.7%). The laboratory parameters include lymphopenia, elevated erythrocyte sedimentation rate, C-reactive protein, lactate dehydrogenase, interleukin-6, serum ferritin, and D-dimer in all six (100%) patients. The chest X-ray at presentation showed bilateral infiltrates in all the patients (100%). We also described electrocardiogram findings, complications, and treatment during hospitalization in detail. One patient died during the hospital course.","J Med Virol","Gayam, Vijay","Konala, Venu M","Naramala, Srikanth","Garlapati, Pavani Reddy","Merghani, Mohamed A","Regmi, Nirajan","Balla, Mamtha","Adapa, Sreedhar","32449972"],"abstract":["Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is spreading at a rapid pace, and the World Health Organization declared it as pandemic on 11 March 2020. Mycoplasma pneumoniae is an \"atypical\" bacterial pathogen commonly known to cause respiratory illness in humans. The coinfection from SARS-CoV-2 and mycoplasma pneumonia is rarely reported in the literature to the best of our knowledge. We present a study in which 6 of 350 patients confirmed with COVID-19 were also diagnosed with M. pneumoniae infection. In this study, we described the clinical characteristics of patients with coinfection. Common symptoms at the onset of illness included fever (six [100%] patients); five (83.3%) patients had a cough, shortness of breath, and fatigue. The other symptoms were myalgia (66.6%), gastrointestinal symptoms (33.3%-50%), and altered mental status (16.7%). The laboratory parameters include lymphopenia, elevated erythrocyte sedimentation rate, C-reactive protein, lactate dehydrogenase, interleukin-6, serum ferritin, and D-dimer in all six (100%) patients. The chest X-ray at presentation showed bilateral infiltrates in all the patients (100%). We also described electrocardiogram findings, complications, and treatment during hospitalization in detail. One patient died during the hospital course."],"journal":"J Med Virol","authors":["Gayam, Vijay","Konala, Venu M","Naramala, Srikanth","Garlapati, Pavani Reddy","Merghani, Mohamed A","Regmi, Nirajan","Balla, Mamtha","Adapa, Sreedhar"],"date":"2020-05-26T11:00:00Z","year":2020,"_id":"32449972","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/jmv.26026","keywords":["sars coronavirus","coronavirus","epidemiology","immune responses","interleukin","pandemics","pathogenesis","respiratory tract","virus classification"],"locations":["USA"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Case Report"],"weight":1,"_version_":1667785213953966081,"score":174.64581},{"pmid":32270500,"title":"Four cases from a family cluster were diagnosed as COVID-19 after 14-day of quarantine period.","text":["Four cases from a family cluster were diagnosed as COVID-19 after 14-day of quarantine period.","Since December, 2019, coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has spread to a lot of countries worldwide(1,2) . On Jan 30, 2020, the World Health Organization (WHO) had declared that the outbreak of COVID-19 is a Public Health Emergency of International Concern. On March 11, 2020, the spread of COVID-19 was declared a pandemic by the WHO. This article is protected by copyright. All rights reserved.","J Med Virol","Chen, Dexiong","Li, Yueping","Deng, Xilong","Huang, Huanliang","Ou, Xueting","Lin, Yuebao","Pan, Xingfei","Lei, Chunliang","32270500"],"abstract":["Since December, 2019, coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has spread to a lot of countries worldwide(1,2) . On Jan 30, 2020, the World Health Organization (WHO) had declared that the outbreak of COVID-19 is a Public Health Emergency of International Concern. On March 11, 2020, the spread of COVID-19 was declared a pandemic by the WHO. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Chen, Dexiong","Li, Yueping","Deng, Xilong","Huang, Huanliang","Ou, Xueting","Lin, Yuebao","Pan, Xingfei","Lei, Chunliang"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32270500","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1002/jmv.25849","topics":["Case Report"],"weight":1,"_version_":1666138491741798400,"score":160.93431},{"pmid":32458578,"title":"COVID-19 encephalopathy masquerading as substance withdrawal.","text":["COVID-19 encephalopathy masquerading as substance withdrawal.","Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), first identified in December 2019 in Wuhan, China, is the virus responsible for the current pandemic known as COVID-19. We report the case of a patient with past medical history of substance abuse who presented with suspected drug overdose. He was agitated and altered in the emergency room and he was treated with benzodiazepines for his agitation. He was admitted for substance withdrawal, however his encephalopathy did not improve and he developed choreiform movements. Metabolic, infectious, and rheumatologic workup was negative until he subsequently tested positive for COVID-19. An MRI was performed which showed multiple focal enhancing lesions primarily affecting the bilateral medial putamen and left cerebellum along with subcortical lesions suggesting COVID-19 encephalopathy. He was given glucocorticoids and his mentation and choreiform movements improved. While neurologic presentations are increasingly becoming more common, encephalopathy with choreiform movements appears to be a rare manifestation of SARS-CoV-2, and may be due to direct viral invasion or, more likely, autoimmune mediated toxicity precipitated by the initial viral infection This article is protected by copyright. All rights reserved.","J Med Virol","Byrnes, Sean","Bisen, Maneesh","Syed, Baseer","Huda, Syed","Siddique, Zaid","Sampat, Parth","Russo, Ronald","Oueida, Zaher","Johri, Geetanjali","Dargon, Ian","32458578"],"abstract":["Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), first identified in December 2019 in Wuhan, China, is the virus responsible for the current pandemic known as COVID-19. We report the case of a patient with past medical history of substance abuse who presented with suspected drug overdose. He was agitated and altered in the emergency room and he was treated with benzodiazepines for his agitation. He was admitted for substance withdrawal, however his encephalopathy did not improve and he developed choreiform movements. Metabolic, infectious, and rheumatologic workup was negative until he subsequently tested positive for COVID-19. An MRI was performed which showed multiple focal enhancing lesions primarily affecting the bilateral medial putamen and left cerebellum along with subcortical lesions suggesting COVID-19 encephalopathy. He was given glucocorticoids and his mentation and choreiform movements improved. While neurologic presentations are increasingly becoming more common, encephalopathy with choreiform movements appears to be a rare manifestation of SARS-CoV-2, and may be due to direct viral invasion or, more likely, autoimmune mediated toxicity precipitated by the initial viral infection This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Byrnes, Sean","Bisen, Maneesh","Syed, Baseer","Huda, Syed","Siddique, Zaid","Sampat, Parth","Russo, Ronald","Oueida, Zaher","Johri, Geetanjali","Dargon, Ian"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32458578","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/jmv.26065","keywords":["coronavirus","immune responses","sars coronavirus","virus classification"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Benzodiazepines"],"topics":["Case Report"],"weight":1,"_version_":1668141322622468096,"score":158.07826},{"pmid":32293711,"title":"Possibly critical role of wearing masks in general population in controlling COVID-19.","text":["Possibly critical role of wearing masks in general population in controlling COVID-19.","Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is now overwhelming spreading in the world. As of April 11, 2020, totally 1.61 million COVID-19 patients were confirmed in more than 200 countries and regions with 99690 deaths. This article is protected by copyright. All rights reserved.","J Med Virol","Han, Guangshu","Zhou, Yi-Hua","32293711"],"abstract":["Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is now overwhelming spreading in the world. As of April 11, 2020, totally 1.61 million COVID-19 patients were confirmed in more than 200 countries and regions with 99690 deaths. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Han, Guangshu","Zhou, Yi-Hua"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32293711","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1002/jmv.25886","keywords":["coronavirus","epidemiology","pandemics","public policy","social science","virus classification"],"topics":["Prevention"],"weight":1,"_version_":1666138494327586817,"score":152.12535},{"pmid":32383174,"title":"High prevalence of olfactory and taste disorder during SARS-CoV-2 infection in outpatients.","text":["High prevalence of olfactory and taste disorder during SARS-CoV-2 infection in outpatients.","Prevalent symptoms of SARS-CoV-2 in reports and metaanalyses refer to cough, fatigue, myalgia and respiratory distress. These represent clinically acknowledged relevant findings of valuable importance, particularly with the requirement for ventilation and hospital bed occupancy in ICUs. There is however a wide discordance with the actual picture of clinical presentation and symptoms in Italy. Here we comment on Sun and coll Metaanlysis with particular nuance to olfactory and taste disorders that very often herald SARS-CoV-2 in our country, particularly in outpatients, and are not reported so far in the medical literature from China. This article is protected by copyright. All rights reserved.","J Med Virol","De Maria, Andrea","Varese, Paola","Dentone, Chiara","Barisione, Emanuela","Bassetti, Matteo","32383174"],"abstract":["Prevalent symptoms of SARS-CoV-2 in reports and metaanalyses refer to cough, fatigue, myalgia and respiratory distress. These represent clinically acknowledged relevant findings of valuable importance, particularly with the requirement for ventilation and hospital bed occupancy in ICUs. There is however a wide discordance with the actual picture of clinical presentation and symptoms in Italy. Here we comment on Sun and coll Metaanlysis with particular nuance to olfactory and taste disorders that very often herald SARS-CoV-2 in our country, particularly in outpatients, and are not reported so far in the medical literature from China. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["De Maria, Andrea","Varese, Paola","Dentone, Chiara","Barisione, Emanuela","Bassetti, Matteo"],"date":"2020-05-09T11:00:00Z","year":2020,"_id":"32383174","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1002/jmv.25995","keywords":["coronavirus","epidemiology","inapparent infection","sars coronavirus","virus classification"],"locations":["Italy","China"],"countries":["China","Italy"],"countries_codes":["CHN|China","ITA|Italy"],"topics":["Diagnosis"],"weight":1,"_version_":1666419683319873537,"score":140.69406}]}